SEC Tracker
Get the app

Iambic Therapeutics IAM

Kurt Von Emster reports stock option grant

Kurt Von Emster, insider filing for Iambic Therapeutics, Inc.

Form
4
Filed
Importance
Routine
  1. Kurt Von Emster received 20,300 stock options
  2. Options vest on Oct 14, 2027
  3. Exercise price is $16
  4. Options expire on Oct 14, 2036

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Iambic Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX